Fig. 7From: Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen-2-ones analogues as anti-cancer agentsBioavailability radar designed compounds 6 (A), 8 (B), 11 (C) and 12 (D)Back to article page